[Federal Register Volume 63, Number 29 (Thursday, February 12, 1998)] [Notices] [Page 7181] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-3608] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Registration By Notice dated October 3, 1997, and published in the Federal Register on October 22, 1997, (62 FR 54856), Norac Company, Inc., 405 S. Motor Avenue, Azusa, California 91702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of tetrahydrocannabinols (7370), a basic class of controlled substance listed in Schedule I. The firm plans to manufacture medication for the treatment of AIDS wasting syndrome and as an antiemetic. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Norac Company, Inc. to manufacture tetrahydrocannabinols is consistent with the public interest at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted. Dated: January 21, 1998. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 98-3608 Filed 2-11-98; 8:45 am] BILLING CODE 4410-09-M